Brain Function During Grasping Task in Three to Nine Months Infants Using fNIRS , the Difference Between Full and Preterm Born Infants

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

This study aims to investigate the neural mechanisms involved in the development of reach-to-grasp function in infants. Reaching and grasping are crucial motor skills that develop early in infancy and are essential for later motor and cognitive milestones. Understanding how these skills emerge and the underlying neural processes can provide valuable insights into both typical and atypical development. The study will focus on infants aged 3 to 9 months, a critical period for the development of reach-to-grasp skills. A total of 100 infants will be recruited, including 50 full-term infants and 50 preterm infants (born \<36 weeks gestational age). Reach-to-grasp function will be evaluated through a cross-sectional assessment at a single time point. Functional near-infrared spectroscopy (fNIRS) will be used as the brain imaging technique to measure brain activity during the reach-to-grasp task. The use of fNIRS will allow for a non-invasive assessment of neural activity in real time, providing insights into the brain mechanisms supporting the development of motor skills. The findings may offer important information about the neural basis of motor development in infancy, particularly in the context of preterm birth.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 3 months
Maximum Age: 9 months
Healthy Volunteers: t
View:

• 3-9 months old

• can tolerate the fNIRS cap

• performs at least 2 grapsing attempts with one hand within one minute when prompting the hand with a toy

Locations
Other Locations
Belgium
hent University, vakgroep revalidatiewetenschappen
RECRUITING
Ghent
Contact Information
Primary
Nele De Bruyn, Phd
nele.debruyn@ugent.be
00329 332 69 21
Backup
Christine Van den Broeck, prof. dr.
christine.vandenbroeck@ugent.be
00329 332 69 21
Time Frame
Start Date: 2022-09-26
Estimated Completion Date: 2027-09-30
Participants
Target number of participants: 100
Treatments
full term infants
infants between 3-9 months old with gestational age more than 36 weeks
preterm infants
infants between 3-9 months old corrected age born with a gestational age less than 36 weeks
Related Therapeutic Areas
Sponsors
Leads: University Ghent

This content was sourced from clinicaltrials.gov